Back

Different left bundle branch block morphologies and response to CRT: a cohort study

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Conduction system pacing 2 Cardiac Resynchronisation Therapy (CRT) EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Athanasios Saplaouras

Onassis Cardiac Surgery Center, Athens (Greece)

6 More presentations in this session

Presentation thumbnail
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings
Doctor M. Pujol-Lopez (Phoenix, US)
Abstract Slides Video
Presentation thumbnail
Long-term mechanical synchrony in left bundle branch area pacing
Doctor A. Estevez Paniagua (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Conduction system pacing: comparing technical and clinical outcomes with lumenless versus stylet-driven leads
Doctor F. Deluca (Rovigo, IT)
Abstract Slides Video
Presentation thumbnail
Impact of baseline QRS morphology on right ventricular function during long-term LBBAP in patients with atrioventricular block
Doctor C. Pestrea (Brasov, RO)
Abstract Slides Video
Presentation thumbnail
Conduction system versus biventricular pacing upgrade in patients with pacing-induced cardiomyopathy
Doctor G. Coluccia (Lecce, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Conduction system pacing 2

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Differences in cardiac resynchronisation therapy's response in patients with non-LBBB QRS complex morphology
thumbnail
Congress Presentation
Strauss criteria for left bundle branch block in cardiac resynchronization therapy: improved response with lower ventricular arrhythmic burden.
thumbnail
Congress Presentation
Impact of left bundle branch block morphology in predicting response to left bundle branch area pacing for cardiac resynchronization therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources